Related Experiment Videos
Circulating endothelin-1 concentrations in patients with chronic hypoxia
C Ferri1, C Bellini, C De Angelis
1Institute of Clinical Medicine, Andrea Cesalpino Foundation, La Sapienza University, Rome, Italy.
Journal of Clinical Pathology
|June 1, 1995
Summary
Chronic hypoxia, a condition of low oxygen, elevates plasma endothelin-1 levels. This peptide may contribute to pulmonary vasoconstriction in lung diseases like COPD.
Area of Science:
- Cardiovascular Physiology
- Respiratory Medicine
- Endocrinology
Background:
- Chronic hypoxia is a hallmark of various lung diseases, including chronic obstructive pulmonary disease (COPD).
- Endothelin-1 is a potent vasoconstrictor peptide implicated in cardiovascular and pulmonary regulation.
Purpose of the Study:
- To investigate the relationship between chronic hypoxia and plasma endothelin-1 levels.
- To assess the role of endothelin-1 in pulmonary hypertension associated with COPD.
Main Methods:
- Studied 15 male COPD patients and 12 healthy male controls.
- Performed pulmonary function tests, echocardiography, and arterial blood gas analysis.
- Measured plasma endothelin-1 concentrations using radioimmunoassay.
Main Results:
- COPD patients exhibited lower PaO2 and higher pulmonary artery pressure than controls.
- Circulating endothelin-1 concentrations were significantly elevated in COPD patients.
- Plasma endothelin-1 levels correlated negatively with PaO2 and positively with pulmonary pressure.
Conclusions:
- Chronic hypoxia is a significant stimulus for endothelin-1 release.
- Elevated endothelin-1 may contribute to pulmonary vasoconstriction in chronic lung diseases.
- Endothelin-1 is a potential mediator in the pathophysiology of pulmonary hypertension in COPD.